Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 451 | 0 | 0 | 0 | 0 |
| Cost of Goods | 448 | N/A | N/A | N/A | N/A |
| Gross Profit | 3 | N/A | N/A | N/A | N/A |
| Operating Expenses | 2,623 | 765 | 880 | 1,031 | 948 |
| Operating Income | -2,172 | -765 | -880 | -1,031 | -948 |
| Interest Expense | 112 | 36 | 27 | 0 | 17 |
| Other Income | 1,127 | -981 | -441 | 1,466 | -1,989 |
| Pre-tax Income | -1,157 | -1,782 | -1,348 | 435 | -2,954 |
| Income Tax | -130 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -1,027 | -1,782 | -1,348 | 435 | -2,954 |
| Net Income | $-1,027 | $-1,782 | $-1,348 | $435 | $-2,954 |
| EPS Basic Total Ops | -0.20 | -0.30 | -0.20 | 0.10 | -0.60 |
| EPS Basic Continuous Ops | -0.15 | -0.33 | -0.25 | 0.08 | -0.57 |
| EPS Diluted Total Ops | -0.30 | -0.30 | -0.20 | 0.00 | -0.60 |
| EPS Diluted Continuous Ops | -0.15 | -0.33 | -0.25 | 0.07 | -0.57 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -0.33 | 0.00 | 0.07 | -0.15 |
| EBITDA(a) | $-1,973 | $-765 | $-879 | $-1,030 | $-947 |